D141-0234 Screening compound: 4-[4-(4-chlorophenyl)-5-({[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-4H-1,2,4-triazol-3-yl]pyridine

D141-0234 Screening compound: 4-[4-(4-chlorophenyl)-5-({[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-4H-1,2,4-triazol-3-yl]pyridine
D141-0234 Screening compound: 4-[4-(4-chlorophenyl)-5-({[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-4H-1,2,4-triazol-3-yl]pyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound D141-0234
4-[4-(4-chlorophenyl)-5-({[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-4H-1,2,4-triazol-3-yl]pyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D141-0234

Molecular Formula

C24H19ClN6O2S (C24 H19 ClN6 O2 S)

Compound Name

4-[4-(4-chlorophenyl)-5-({[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-4H-1,2,4-triazol-3-yl]pyridine

IUPAC name

4-[4-(4-chlorophenyl)-5-({[3-(4-ethoxyphenyl)-124-oxadiazol-5-yl]methyl}sulfanyl)-4H-124-triazol-3-yl]pyridine

SMILES

CCOc(cc1)ccc1-c1noc(CSc2nnc(-c3ccncc3)n2-c(cc2)ccc2Cl)n1

InChI

InChI=1S/C24H19ClN6O2S/c1-2-32-20-9-3-16(4-10-20)22-27-21(33-30-22)15-34-24-29-28-23(17-11-13-26-14-12-17)31(24)19-7-5-18(25)6-8-19/h3-14H,2,15H2,1H3

InChI Key

FEWDHUYOFBZWPS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14812500

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.97

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.651

Distribution Coefficient, logD

5.651

Water Solubility, LogSw

-6.15

Polar Surface Area

72.607

Acid Dissociation Constant (pKa)

26.55

Base Dissociation Constant (pKb)

2.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

D141-0234 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with D141-0234 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D141-0234?
Check Price and Availability of D141-0234, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D141-0234 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D141-0234
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D141-0234
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D141-0234 available by request